Regenerative medicine company Histogen has been issued a US patent for its method of triggering the de-differentiation of fibroblast cells into multipotent stem cells through low oxygen and special culture conditions.
http://www.prweb.com/releases/2013/9/prweb11083274.htm
http://www.prweb.com/releases/2013/9/prweb11083274.htm
No comments:
Post a Comment